CEA CAR-T, CD38 ADC, and Seprehvir are our product candidates for the treatment of various cancers
| Brain | EGFRvIII |
| Head and Neck | ERBB family |
| Lung | CEA, HER2, MSLN |
| Pleura | FAP, MSLN |
| Breast | CEA, cMET, HER2, MSLN |
| Gastric | CEA, HER2 |
| Liver | GPC3 |
| Colon | CEA |
| Pancreas | CEA, MSLN |
| Renal | VEGFR2 |
| Ovarian | FR, HER2, MSLN, MUC16 |
| Prostate | PSMA |
| Skin | GD2, VEGFR2 |
| Bone | GD2, HER2 |
| Soft Tissue | GD2, HER2 |
| Neural | GD2, L1-CAM |
